Blotter

The ASBMB urges passage of FY20 omnibus with investments in science

Spending package sets a minimum 3% increase for NIH’s institutes and centers
Benjamin Corb
Dec. 16, 2019

Today’s two-part omnibus spending package — which would fund the government for fiscal year 2020 — is a praiseworthy piece of bipartisan legislation that prioritizes investments in the American scientific enterprise. As the details of the spending plan come into focus, lawmakers should be commended for their commitment to investments in scientific research that ultimately will lead to breakthroughs that will improve the quality of life and well-being of not only Americans but also of populations around the globe.

Specifically, we applaud the continuation of investments in the National Institutes of Health. If passed, the legislation would make FY20 the fifth year in a row of multibillion-dollar increases, helping the NIH’s budget grow to a record $41.7 billion. Perhaps most importantly, the legislation sets a minimum 3% increase in funding at each of the NIH’s 28 institutes and centers. This ensures that research of all kinds, from discovery to clinical efforts, will benefit.

The National Science Foundation and the Department of Energy’s Office of Science are also slated to see increases in FY20.

We appreciate that Congress and the White House support scientific research, and we thank Democratic and Republican negotiators for their hard work and support for the research that our members do in laboratories across the country.

We urge swift passage of this legislation in Congress and ask that President Donald Trump sign it into law.

Benjamin Corb

Benjamin Corb is director of public affairs at ASBMB.

Join the ASBMB Today mailing list

Sign up to get updates on articles, interviews and events.

Latest in Policy

Policy highlights or most popular articles

Why is the FDA funded in part by the companies it regulates?
Funding

Why is the FDA funded in part by the companies it regulates?

July 4, 2021

The U.S. Food and Drug Administration receives almost half its funding from companies it regulates, such as drug and medical device makers. Is this something you should be concerned about?

ASBMB calls for changes to Title IX policy
Blotter

ASBMB calls for changes to Title IX policy

June 16, 2021

Society urges Department of Education to revise rule created by Trump administration.

Rethinking the NIH review system
Reimagining

Rethinking the NIH review system

June 10, 2021

Proposals for change include a tiered grant funding system, tweaks to scoring and criteria, internal reviews and a continuous submission system.

Analysis: Mounting pressure on China about coronavirus ‘lab leak’ could backfire
News

Analysis: Mounting pressure on China about coronavirus ‘lab leak’ could backfire

June 9, 2021

Where the coronavirus originated remains a mystery, and the Chinese are bucking demands to let investigators see more.

Two years of the DOJ’s China Initiative
Blotter

Two years of the DOJ’s China Initiative

April 14, 2021

Despite the agency’s intense scrutiny of scientists at academic institutions, few have been convicted, and none has been accused of economic espionage.

Early-career scientists need pandemic relief funds
Blotter

Early-career scientists need pandemic relief funds

March 3, 2021

ASBMB recommends that Congress provide an additional year of funding for students and early-career researchers whose grants expired in 2020 before they could complete their training and/or research.